trending Market Intelligence /marketintelligence/en/news-insights/trending/jPxq14dxQ1a0JbWYWH6taA2 content esgSubNav
In This List

Aeglea Biotherapeutics starts common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Aeglea Biotherapeutics starts common stock offering

Aeglea Biotherapeutics Inc. started an underwritten public offering of common shares to raise funds for research and development of its product candidates.

JonesTrading Institutional Services LLC is the sole book-runner for the offering, which is yet to be priced. The biotechnology company plans to grant the underwriter a 30-day option to buy up to an additional 15% of the shares offered.